The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

BACKGROUND: Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a careful dose-selection process. We report the first safety and immunogenicity results in volunteers receiving 3 × 10(5) plaque-forming units (pfu) of th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Infect Dis
Autors principals: Huttner, Angela, Dayer, Julie-Anne, Yerly, Sabine, Combescure, Christophe, Auderset, Floriane, Desmeules, Jules, Eickmann, Markus, Finckh, Axel, Goncalves, Ana Rita, Hooper, Jay W, Kaya, Gürkan, Krähling, Verena, Kwilas, Steve, Lemaître, Barbara, Matthey, Alain, Silvera, Peter, Becker, Stephan, Fast, Patricia E, Moorthy, Vasee, Kieny, Marie Paule, Kaiser, Laurent, Siegrist, Claire-Anne
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6624136/
https://ncbi.nlm.nih.gov/pubmed/26248510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00154-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars